Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Pain between the shoulder and neck, and has now moved up to 1" behind the left ear, 2" into the head and down along the hair line in the head; Pain in left shoulder area; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Pain between the shoulder and neck, and has now moved up to 1" behind the left ear, 2" into the head and down along the hair line in the head) and VACCINATION SITE PAIN (Pain in left shoulder area) in a 9-decade-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 3032233) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (approximately on Jan 2022) in January 2022 and Cardiac stent placement (had heart stents). Previously administered products included for Drug use for unknown indication: ALOGLIPTIN (12.5 mg) and EMPAGLIFLOZIN (25 mg). Past adverse reactions to the above products included No adverse effect with ALOGLIPTIN and EMPAGLIFLOZIN. Concurrent medical conditions included Type 2 diabetes mellitus.    On 16-May-2024, the patient received eighth dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) .5 milliliter. On an unknown date, the patient experienced PAIN (Pain between the shoulder and neck, and has now moved up to 1" behind the left ear, 2" into the head and down along the hair line in the head) and VACCINATION SITE PAIN (Pain in left shoulder area). The patient was treated with Naproxen at an unspecified dose and frequency. At the time of the report, PAIN (Pain between the shoulder and neck, and has now moved up to 1" behind the left ear, 2" into the head and down along the hair line in the head) and VACCINATION SITE PAIN (Pain in left shoulder area) had not resolved.            No concomitant medications were reported.   The patient's age was reported as almost 84 years old.  Past drug included Glucoside (10 mg 4 tablets a day).  In 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 0.5 milliliter (lot number not provided). On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 0.5 milliliter (lot number 030M20A). On 13-Mar-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 0.5 milliliter (lot number 038A21A). On 04-Nov-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) dosage 0.5 milliliter (lot number 012F21A). On 02-Jun-2022, the patient received fifth dose of mRNA-1273 (Spikevax) (Intramuscular use) 0.5 milliliter (lot number 059M21A). On 27-Oct-2022, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular use) 0.5 milliliter (lot number 021HA22A). On 02-NOV-2023, the patient received seventh dose of Spikevax 2023-2024 (Intramuscular use) 0.5 milliliter (lot number not provided).  It was reported that his reaction started with the first COVID vaccine back in 2020 and it went worse and worse, and he had 6 shots of Moderna. His pain has moved from his left shoulder area, between the shoulder and neck, and then moved up to 1 inch behind the left ear, 2 inches into the head and down along the hair line in the head. It went worse in the last few weeks. He was unsure if he spoke with HCP regarding how he was feeling, but he mentioned it every time when he received his Covid vaccine. He would like the pain to go away.   It was unknown if the patient experienced any additional symptoms or events.   This case was linked to MOD-2023-728819 (Patient Link).